| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |